Curis to Present at the Sachs-Bloomberg 4th Annual North America Forum for Investing and Partnering in Biotech and MedTech.CAMBRIDGE, Mass. -- Curis, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CRIS) announced today that Daniel Passeri, Curis' President and Chief Executive Officer, will present an update of Curis' business and collaborations at the Sachs-Bloomberg 4th Annual North American Forum The North American Forum is an annual meeting of U.S., Canadian and Mexican government and business representatives to discuss issues related to continental economic and social integration. The Forum is chaired jointly by former U.S. for Investing and Partnering in Biotech and MedTech to be held on March 16 and 17, 2005, at The Fairmont Copley Plaza in Boston, MA. Mr. Passeri will present on Wednesday, March 16, at 12:10 PM, and the presentation will be webcast at: http://www.sachsforum.com It will be archived for 30 days following the conference. Shortly after Mr. Passeri's remarks have concluded, a link to the presentation webcast will also be available on the Investor Relations Investor relations The process by which the corporation communicates with its investors. section of Curis' website at www.curis.com. A PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format. version of the current corporate presentation is also available at the Homepage section of Curis' website. About Curis, Inc. Curis, Inc. is a therapeutic drug development company. The Company's technology focus is on regulatory pathways that control repair and regeneration. Curis' product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer (under partnership with Genentech, which also includes a co-development collaboration between Curis and Genentech for a basal cell carcinoma basal cell carcinoma n. A slow-growing, locally invasive, but rarely metastasizing neoplasm of the skin derived from basal cells of the epidermis or hair follicles. Also called basal cell epithelioma. product candidate), kidney disease Kidney Disease Definition Kidney disease is a general term for any damage that reduces the functioning of the kidney. Kidney disease is also called renal disease. (licensed to Ortho Biotech, a subsidiary of Johnson & Johnson), neurological disorders (partnered with Wyeth Pharmaceuticals), hair growth, and cardiovascular disease. For more information, please visit the Curis web site at www.curis.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion